Jeffrey Humphrey

Chief Medical Officer, Constellation Pharmaceuticals (United States).

Companies

Lantheus Holdings, Inc.Chief Medical Officer Jun 6, 2024 to Jun 20, 2024¹
Cyteir Therapeutics, Inc.Board member Dec 16, 2021 to Feb 7, 2023²
Magenta TherapeuticsChief Medical Officer Oct 4, 2021 to Aug 1, 2022³
Constellation Pharmaceuticals (United States)Chief Medical Officer Jul 8, 2020 to Jul 19, 2021⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Lantheus Holdings, Inc. LNTH9,076 shares⁵$907.5K at $99.99Jun 17, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 17, 2024Granted 9,076 shares at $82.63 of Lantheus Holdings, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLantheus Holdings, Inc., Chief Medical Officer
2
SEC EDGARCyteir Therapeutics, Inc., Board member
3
SEC EDGARMagenta Therapeutics, Chief Medical Officer
4
SEC EDGARConstellation Pharmaceuticals (United States), Chief Medical Officer
5
SEC EDGARLantheus Holdings, Inc. shares after the filing of Jun 17, 2024